APA (7th ed.) Citation

X, L., R, W., X, M., J, Y., S, Z., Z, Z., . . . W, D. (2026). Glaucine suppresses IL-16/CD4 to alleviate neuropathic pain via spinal p56lck-NMDA receptor signaling. Naunyn-Schmiedeberg's archives of pharmacology, 399(5), 6485. https://doi.org/10.1007/s00210-025-04810-8

Chicago Style (17th ed.) Citation

X, Li, et al. "Glaucine Suppresses IL-16/CD4 to Alleviate Neuropathic Pain via Spinal P56lck-NMDA Receptor Signaling." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 5 (2026): 6485. https://doi.org/10.1007/s00210-025-04810-8.

MLA (9th ed.) Citation

X, Li, et al. "Glaucine Suppresses IL-16/CD4 to Alleviate Neuropathic Pain via Spinal P56lck-NMDA Receptor Signaling." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 5, 2026, p. 6485, https://doi.org/10.1007/s00210-025-04810-8.